Skip to content
Clinical ResearchResearch compound

Sibutramine (Meridia, Reductil)

Withdrawn appetite-suppressant drug: pulled in 2010 over heart risks, and now turns up undeclared in “herbal” slimming products.

Available at
DEUSPOWER logo
DEUSPOWERProduct page

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Sibutramine (Meridia, Reductil) vial

DETAILED OVERVIEW

What is Sibutramine (Meridia, Reductil)?

Sibutramine was once a prescription slimming drug, sold from 1997 as Meridia (US) and Reductil (Europe). It blocks the reuptake of serotonin and norepinephrine, two brain messengers, so fullness arrives sooner and body weight falls measurably.

In a large trial, patients at high cardiovascular risk had more non-fatal heart attacks and strokes than on placebo, so the drug was withdrawn in 2010. Losing weight itself did no harm: the damage came from the drug’s norepinephrine effect, which raises blood pressure and heart rate. Together with some antidepressants, migraine drugs and MAO inhibitors it can cause life-threatening serotonin syndrome. It must not be used in heart disease or pregnancy. Today it matters mainly because it is the most common undeclared adulterant in “herbal” slimming products, so users cannot know what they are taking. It is banned as a stimulant in competition.

Mechanism

Serotonin and norepinephrine reuptake inhibition, increased satiety.

Why it was withdrawn

More non-fatal heart attacks and strokes than with placebo (10,744 patients)

Date of withdrawal

EMA January 2010, FDA October 2010. No longer marketed anywhere as an approved drug.

Relevance today

The most common undeclared adulterant in "herbal" slimming products.

Half-life

Active metabolites ~14-16 h, hence once-daily dosing.

Data console

Lab data

Androgenic:AnabolicNot applicable: this compound has no androgenic action.
AR bindingSerotonin and norepinephrine transporter inhibitor with…
Active half-life~14-16 h (aktív metabolitok)
Detection windowDetectable in urine by mass spectrometry. Banned in competition (WADA S6).
AromatizationNO. Sibutramine is not a steroid, is not a substrate of aromatase and has no hormonal action.
HepatotoxicityLOW. Sibutramine is not 17-alpha-alkylated and liver injury is not among its characteristic risks. The limiting safety factor is cardiovascular rather than hepatic: blood pressure and pulse, not ALT/AST.

Safety

Side effects, stop signs, contraindications

Side effects · 5

  • Rising blood pressure and heart rate: a direct consequence of the noradrenergic action, and precisely what led to withdrawal of the approval.
  • Increased cardiovascular events: in SCOUT, non-fatal myocardial infarction and stroke were more frequent than on placebo.
  • Risk of serotonin syndrome: combined with an SSRI, SNRI, triptan or MAO inhibitor it can be life-threatening.
  • Insomnia, dry mouth, constipation, anxiety and irritability: the most common, dose-dependent complaints.
  • Undeclared presence in slimming products: users often do not know they are taking it, making interactions and cardiac risk impossible to guard against.

Contraindications · 5

  • Any known cardiovascular disease: coronary disease, prior infarction or stroke, heart failure, arrhythmia. SCOUT demonstrated harm in exactly this population.
  • Untreated or poorly controlled hypertension.
  • Concurrent serotonergic medication (SSRI, SNRI, triptan, MAO inhibitor, tramadol): risk of serotonin syndrome.
  • Pregnancy and breastfeeding, as well as hyperthyroidism and narrow-angle glaucoma.
  • Competitive sport under testing: WADA bans stimulants in competition (S6).

Related Performance Compounds

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Sibutramine (Meridia, Reductil)?

Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.